Tag Archives: Emerald Health Therapeutics

Emerald Health Northern Vine Labs

Emerald Health Therapeutics Receives $26.5 Million from Exercise of Warrants and Triggers Acceleration of 721,700 Remaining $2.00 Warrants

Emerald Health Therapeutics Receives $26.5 Million from Exercise of Warrants and Triggers Acceleration of 721,700 Remaining $2.00 Warrants

VICTORIA, British Columbia, Dec. 21, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (“Emerald” or the “Company”) (TSXV: EMH; OTCQX: EMHTF) has elected to exercise its right to accelerate the exercise of $2.00 common share purchase warrants (“Warrants”) issued by the Company on February 10, 2017.

Emerald Health Northern Vine Labs

Emerald Health Announces No Material Change

VICTORIA, British Columbia, Dec. 13, 2017 /Weed Wire/ — Emerald Health Therapeutics, Inc. (TSXV: EMH; OTCQX: EMHTF) (the “Company”) is issuing this press release in response to a request by the Investment Industry Regulatory Organization of Canada to comment on recent trading activity of its stock.

Emerald Health Northern Vine Labs

Emerald Health Therapeutics, Inc. Acquires Shares of Vanc Pharmaceuticals Inc.

VICTORIA, British Columbia, Nov. 29, 2017 /Weed Wire/ — Emerald Health Therapeutics, Inc. (TSXV: EMH; OTCQX: EMHTF) (“Emerald” or the “Company”) announces that it acquired today 1,666,6667 units (the “Units”) of Vanc Pharmaceuticals Inc. (“Vanc”) of Suite 810 – 789 West Pender Street, Vancouver, British Columbia, V6C 1H2 at a price of $0.15 per Unit pursuant to a private placement offering (the “Transaction”).

Emerald Health Northern Vine Labs

Emerald Health Therapeutics Completes Investment in Licensed Dealer Northern Vine

VICTORIA, British Columbia, Nov. 21, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announced today that it has completed its previously announced investment of $2.5 million into Northern Vine Canada Inc. (“Northern Vine”) to acquire 53% of the company and appoint three of its four directors.

Emerald Health Northern Vine Labs

Emerald Health Therapeutics Appoints Robert C. Hill, CPA, CA as Chief Financial Officer and Promotes Cheryl Evans, CPA, CA to Vice President Finance

VICTORIA, British Columbia, Nov. 20, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (TSXV: EMH; OTCQX: EMHTF) (“Emerald”) today announced the appointment of Robert C. Hill, CPA, CA, as the Company’s Chief Financial Officer and the promotion of Cheryl L. Evans, CPA, CA, to Vice President Finance.

First Look at the Proposed Canadian Cannabis Tax Framework

First Look at the Proposed Canadian Cannabis Tax Framework

While several provinces have announced their plans for recreational cannabis distribution and retail operations, industry stakeholders have been waiting for an announcement on the Canadian cannabis tax framework and that moment has now arrived.

Emerald Health Northern Vine Labs

Emerald Health Therapeutics to Acquire Control of Licensed Dealer Northern Vine

VICTORIA, British Columbia, Oct. 26, 2017 /Weed Wire/ – Emerald Health Therapeutics Inc. (“Emerald”) (EMH.V) (EMHTF) announced today that it has signed a definitive agreement (the “Agreement”) with Northern Vine Canada Inc. (“Northern Vine”) and Abattis Bioceuticals Corp. (“Abattis”) (CSE:ATT) (ATTBF) to invest $2.5 million into Northern Vine to acquire 53% of the company and appoint three of its four directors. Abattis will continue to hold the remaining 47% of Northern Vine.

Emerald Health Northern Vine Labs

Emerald Health Therapeutics Expands its Cannabis Supply with Purchase from Supreme Pharmaceuticals

VICTORIA, British Columbia, Sept. 20, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (EHT) (TSXV: EMH; OCTQX: EMHTF) today announced that its wholly owned subsidiary, Emerald Health Botanicals Inc., has completed a purchase of dried cannabis from Supreme Pharmaceuticals Inc.’s (Supreme) (TSXV: FIRE) subsidiary, 7ACRES.

Emerald Health

Emerald Launches Market Leading CBD Oil and Supports Proposed Cannabis Legislation

VICTORIA, British Columbia, April 17, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (TSXV: EMH) (“Emerald” or the “Company”) today announced the launch of its CBD-25< and CBD-50 medical cannabis oils containing 25mg and 50mg of CBD per ml.


Top